Diffuse large B-cell lymphoma-recurrent
Clinical trials for Diffuse large B-cell lymphoma-recurrent explained in plain language.
Never miss a new study
Get alerted when new Diffuse large B-cell lymphoma-recurrent trials appear
Sign up with your email to follow new studies for Diffuse large B-cell lymphoma-recurrent, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a drug duo outsmart returning lymphoma?
Disease control Recruiting nowThis phase II trial is testing whether combining two drugs—glofitamab and chidamide—can help people with diffuse large B-cell lymphoma that has come back or not responded to earlier treatment. The study will enroll about 22 adults and measure how many achieve a complete response …
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA-RECURRENT
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug cocktail aims to boost CAR T-Cell success in lymphoma
Disease control Recruiting nowThis early-phase trial is testing whether adding two drugs—CC-99282 and rituximab—can help people with non-Hodgkin lymphoma who didn't get a good result from CAR T-cell therapy. The study will enroll 18 adults with relapsed or refractory B-cell lymphoma. Researchers are looking f…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA-RECURRENT
Phase 1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC